Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today published its 2024 Annual Report along with the invitation to its first Annual General Meeting which will be held on ...
Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community ...
Galderma will present new data from across its portfolio, including findings from the RELAX and EXPRESSION studies on Relfydess® (RelabotulinumtoxinA ...
Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7-11, 2025 in Orlando ...
Cetaphil invited a long list of influencers from 10 different markets, according to the campaign. They included Catriona Gray, a Filipino model; Noor Naim, a YouTube star from Iraq; and Griffin ...
In a report released today, Cedric Besnard from Citi maintained a Buy rating on Galderma Group AG (GALD – Research Report), with a price target ...
Skincare product maker Galderma, and pharmaceutical company Sandoz both returned to their home market this week, bringing ...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY ...
As part of the Placement, EQT received gross proceeds of c. CHF 354 million. The Placement was completed on 13 March 2025. BNP Paribas, BofA Securities, Goldman Sachs, Morgan Stanley and UBS acted as ...
In a report released yesterday, Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG (GALD – Research Report), with ...
Galderma CEO, Flemming Ornskov said he intends to talk to US retailers about the trade tariffs slapped on imported goods by ...
Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results